v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotype

Jason S Iacovoni1, Steven B Cohen, Thorsten Berg

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Oncogene
|May 11, 2004
PubMed

Insights

Oncogenic transcription factor v-Jun targets Akap12 and Marcks, known tumor suppressor genes, in mouse cells. Overexpressing these genes reverses the transformed cell phenotype, indicating their cooperative role in maintaining a non-transformed state.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • The oncogenic transcription factor v-Jun drives cellular transformation.
  • Understanding v-Jun's regulatory targets is crucial for cancer research.
  • Tumor suppressor genes play a vital role in preventing uncontrolled cell growth.

Purpose of the Study:

  • To identify and characterize the DNA targets of v-Jun in murine C3H 10T1/2 cells.
  • To investigate the functional roles of identified v-Jun targets in cellular transformation.
  • To explore the cooperative mechanisms between tumor suppressor genes in reversing oncogenic phenotypes.

Main Methods:

  • Utilized DNA microarrays to identify v-Jun targets in C3H 10T1/2 cells.
  • Generated and analyzed a panel of six cell lines to assess gene expression patterns.
  • Performed overexpression studies to evaluate the functional impact of target genes on cellular phenotype.

Main Results:

  • Identified Akap12 and Marcks as downregulated v-Jun targets, both recognized as tumor suppressor genes.
  • Demonstrated that overexpression of Akap12 or Marcks in v-Jun-transformed cells reverses the transformed phenotype.
  • Observed that Akap12 and Marcks re-expression is interdependent, suggesting cooperative tumor suppression.
  • Found that the upregulated target Sprr1a expression correlates with the transformed phenotype.

Conclusions:

  • Akap12 and Marcks cooperate to suppress the v-Jun-driven transformed phenotype.
  • These tumor suppressor genes are key players in maintaining the non-transformed state.
  • Sprr1a serves as a potential biomarker for the transformed state induced by v-Jun.

Related Concept Videos

Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Cellular Differentiation00:57

Cellular Differentiation

How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...